A comparison of the bioactivity and phytochemical profile of three different cultivars of globe amaranth: red, white, and pink by Liberal, Ângela et al.
Food &
Function
PAPER
Cite this: Food Funct., 2016, 7, 679
Received 5th November 2015,
Accepted 2nd December 2015
DOI: 10.1039/c5fo01342a
www.rsc.org/foodfunction
A comparison of the bioactivity and phytochemical
proﬁle of three diﬀerent cultivars of globe
amaranth: red, white, and pink†
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Lillian Barros,a Montserrat Dueñas,c Celestino Santos-Buelga,c Rui M. V. Abreua and
Isabel C. F. R. Ferreira*a
The phytochemical proﬁles and bioactivities of red, white and pink globe amaranth (Gomphrena haa-
geana K., Gomphrena globosa var. albiﬂora and Gomphrena sp., respectively), much less studied than the
purple species (G. globosa L.), were compared. The chemical characterization of the samples included
the analysis of macronutrients and individual proﬁles of sugars, organic acids, fatty acids, tocopherols, and
phenolic compounds. Their bioactivity was evaluated by determining the antioxidant and anti-inﬂamma-
tory activities; the absence of cytotoxicity was also determined. Red and pink samples showed the highest
sugar content. Otherwise, the white sample gave the highest level of organic acids, and together with the
pink one showed the highest tocopherol and PUFA levels. Quercetin-3-O-rutinoside was the major
ﬂavonol in white and pink samples, whereas a tetrahydroxy-methylenedioxyﬂavone was the major com-
pound in the red variety, which revealed a diﬀerent phenolic proﬁle. The pink globe amaranth hydro-
methanolic extract revealed the highest antioxidant activity, followed by those of red and white samples.
The anti-inﬂammatory activity was more relevant in red and pink varieties. None of the samples presented
toxicity in liver cells. Overall, these samples can be used in bioactive formulations against inﬂammatory
processes and in free radical production.
1. Introduction
Medicinal plants play a vital role in the health and healing of
man, not only in traditional medicine but also as one of the
major sources of drugs.1 Plants synthesize a variety of second-
ary metabolites, many of which are bioactive and could have
commercial interest as pharmaceutical compounds, being
capable of protecting against and treating various diseases.2
Recently, there has been an increasing interest in the thera-
peutic potential of plants as antioxidants, reducing free rad-
icals that induce tissue injury, and as anti-inflammatories.
Although several synthetic drugs are commercially available,
their safety and toxicity is a concern, so there is a tendency to
substitute them by natural compounds.3
Oxidative stress and inflammation play critical roles in the
pathogenesis of many diseases, such as cancer, cardiovascular
disease, arthritis or obesity.4 Oxidative stress occurs when the
balance between pro-oxidants and antioxidants is disturbed,
resulting in tissue accumulation of free radicals and other
reactive oxygen species (ROS). If the human body does not
eliminate these harmful products, they may cause oxidative
damage to functional macromolecules such as DNA, proteins
and lipids.5 Inflammation is one of the body’s self-defense
systems that is classified as part of our innate immunity. Thus,
bacterial or viral infections trigger numerous immunological
events, including the production of cytokines, chemokines,
and inflammatory mediators such as nitric oxide (NO), prosta-
glandin E2 (PGE2) or tumor necrosis factor (TNF)-α,6,7 whose
activation is mediated by nuclear factor-kappa B (NF-κB), a
transcription factor that regulates the transcription of DNA,8
as well as the migration and infiltration of leukocytes, the
increased expression of surface molecules such as MHC
(Major Histocompatibility Complex) molecules, complement
receptors, and the release of hydrolytic enzymes.9
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Bioactive molecules such as phenolic compounds, qui-
nones, vitamins, coumarins, and alkaloids, are present in a
large number of plant species.10 Phenolic compounds are the
most numerous and ubiquitously distributed groups of plant
secondary metabolites, presenting a wide range of biological
eﬀects mainly related to their antioxidant capacity due to the
presence of H-donating hydroxyl groups.11 It is also strongly
suggested in the literature that plant polyphenols inhibit
the inflammation process by regulating the production of
pro-inflammatory molecules, such as TNF-α,12 leukocyte
adhesion, and NO, all produced during inflammatory reac-
tions.13,14 Inflammatory pathways simultaneously contribute
to and are regulated by oxidative stress. In fact, NO reacts
with free radicals, such as superoxides, to produce highly
damaging peroxynitrites, which can oxidize low-density lipo-
proteins that lead to irreversible damage in cell membranes.
Hence, inhibition of the production of such pro-inflamma-
tory molecules (NO and TNF-α) is expected to have a thera-
peutic value as antioxidant agents and against inflammatory
diseases.13,15
Gomphrena sp. is a comestible and commercial ornamental
plant commonly known as globe amaranth or bachelor button
that belongs to the family Amaranthaceae.16 Plants of this
family are particularly predominant in South America, consist-
ing of approximately 120 species, which are employed in folk
medicine in the treatment of several diseases due to their bio-
logical activities, including antimicrobial,17 antioxidant, cyto-
toxic,18 and hypotensive activities,19 and they also possess
nutritive value.20
Recent studies have focused mainly on the most common
cultivar, purple globe amaranth, dealing with its phytochem-
ical composition,20,21 antimicrobial, antioxidant and cytotoxic
activities, and cardiovascular eﬀects,18,22,23 as well as its med-
icinal benefits.24 Nevertheless, to the best of our knowledge,
other Gomphrena species are still poorly or not studied and,
since the consumption data indicate that these plants are
widely employed around the world for various purposes,
especially their traditional use as infusions in order to treat
throat disorders, hence it seems of great interest to explore
their bioactive potential.
Therefore, the aim of this study was to compare the phyto-
chemical profile and bioactive properties of diﬀerent varieties
of globe amaranth (red, white and pink), and contribute to the
characterization of the less studied Gomphrena species.
2. Materials and methods
2.1 Samples
Three diﬀerent cultivars (red, white and pink) of Gomphrena
species, commonly known as globe amaranth, were obtained
from “Cantinho das Aromáticas”, organic farms from Vila
Nova de Gaia (Portugal), as dry flower material (ESI†). Red,
white and pink dried flower samples corresponded to Gom-
phrena haageana K., Gomphrena globosa var. albiflora and Gom-
phrena sp., respectively.
2.2 Standards and reagents
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8%
were of HPLC grade from Fisher Scientific (Lisbon, Portugal).
Fatty acid methyl ester (FAME) reference standard mixture 37
(standard 47885-U) was purchased from Sigma (St Louis, MO,
USA), as also were other individual fatty acid isomers,
trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid),
L-ascorbic acid, tocopherol, sugar and organic acid standards.
Racemic tocol, 50 mg mL−1, was purchased from Matreya
(Pleasant Gap, PA, USA). Phenolic standards were from
Extrasynthèse (Genay, France). 2,2-Diphenyl-1-picrylhydrazyl
(DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA).
Dulbecco’s modified Eagle’s medium, Hank’s balanced salt
solution (HBSS), fetal bovine serum (FBS), L-glutamine,
trypsin-EDTA, penicillin/streptomycin solution (100 U mL−1
and 100 mg mL−1, respectively) were purchased from Gibco
Invitrogen Life Technologies (Paisley, UK). Sulforhodamine B,
trypan blue, trichloroacetic acid (TCA) and Tris were purchased
from Sigma Chemical Co. (Saint Louis, MO, USA). RAW264.7
cells were purchased from ECACC (“European Collection of
Animal Cell Culture”) (Salisburg, UK), lipopolysaccharide (LPS)
from Sigma and DMEM medium from HyClone. The Griess
Reagent System Kit was purchased from Promega, and dexa-
methasone was purchased from Sigma. Water was treated in a
Milli-Q water purification system (TGI Pure Water Systems,
Greenville, SC, USA).
2.3 Nutritional composition
2.3.1 Nutritional value. The samples were analyzed for
chemical composition (protein, fat, carbohydrates and ash)
using the AOAC procedures.25 The crude protein content of the
samples (N × 6.25) was estimated by the macro-Kjeldahl
method; crude fat was determined using a Soxhlet apparatus
by extracting a known weight of the sample with petroleum
ether; the ash content was determined by incineration at 600 ±
15 °C. Total carbohydrates were calculated by diﬀerence and
total energy was calculated according to the following
equation: Energy (kcal) = 4 × (g protein + g carbohydrates) +
9 × (g fat).
2.3.2 Sugars. Free sugars were determined via high per-
formance liquid chromatography coupled to a refraction index
detector (HPLC-RI), after an extraction procedure previously
described by the authors26 using melezitose as the internal
standard (IS). Equipment consisted of an integrated system
with a pump (Knauer, Smartline system 1000, Berlin,
Germany), a degasser system (Smartline manager 5000), an
auto-sampler (AS-2057 Jasco, Easton, MD, USA) and an RI
detector (Knauer Smartline 2300). Data were analyzed using
Clarity 2.4 Software (DataApex, Prague, Czech Republic). The
chromatographic separation was achieved with a Eurospher
100-5 NH2 (Knauer) column (5 µm, 4.6 × 250 mm) operating at
35 °C (7971 R Grace oven). The mobile phase was acetonitrile/
deionized water, 70 : 30 (v/v) at a flow rate of 1 mL min−1. The
compounds were identified by chromatographic comparisons
with authentic standards. Quantification was performed using
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the internal standard method and sugar contents were further
expressed in g per 100 g of dry weight.
2.3.3 Organic acids. Organic acids were determined fol-
lowing a procedure previously described by the authors.27
The analysis was performed using a Shimadzu 20A series
UFLC (Shimadzu Corporation, Kyoto, Japan). Separation was
achieved on a SphereClone (Phenomenex, Torrance, CA, USA)
reverse phase C18 column (5 μm, 4.6 × 250 mm) thermo-
stated at 35 °C. Elution was performed with sulphuric acid
3.6 mM using a flow rate of 0.8 mL min−1. Detection was
carried out in a PDA, using 215 nm and 245 nm (for ascorbic
acid) as preferred wavelengths. The organic acids found were
quantified by a comparison of the area of their peaks with
calibration curves obtained from commercial standards of
each compound. For quantitative analysis, calibration curves
were prepared from diﬀerent standard compounds: oxalic
acid (y = 107x + 96 178; R2 = 0.999); malic acid (y = 952 269x
+ 17 803; R2 = 1); fumaric acid (y = 172 760x + 52 193; R2 =
0.999). The results were expressed in g per 100 g of dry
weight.
2.3.4 Tocopherols. Tocopherols were determined following
a procedure previously described by the authors.26 Analysis
was performed by HPLC (equipment described above), and a
fluorescence detector (FP-2020; Jasco) programmed for exci-
tation at 290 nm and emission at 330 nm. Chromatographic
separation was achieved with a Polyamide II (YMC Waters,
Milford, MA, USA) normal-phase column (5 μm, 4.6 mm ×
250 mm), operating at 35 °C. The mobile phase used was a
mixture of n-hexane and ethyl acetate (70 : 30, v/v) at a flow rate
of 1 mL min−1. The compounds were identified via chromato-
graphic comparisons with authentic standards. Quantification
was based on the fluorescence signal response of each stan-
dard, using the IS (tocol) method and by using calibration
curves obtained from commercial standards of each com-
pound. The results were expressed in mg per 100 g of dry
weight.
2.3.5 Fatty acids. Fatty acids were determined by gas–
liquid chromatography with a flame ionization detection
(GC-FID)/capillary column as described previously by the
authors.26 The analysis was carried out with a DANI model
GC 1000 instrument equipped with a split/splitless injector, a
flame ionization detector (FID at 260 °C) and a Macherey-
Nagel column (30 m × 0.32 mm i.d. × 0.25 μm df, Bethlehem,
PA, USA). The oven temperature program was as follows: the
initial temperature of the column was 50 °C, held for 2 min,
then a 30 °C min−1 ramp to 125 °C, a 5 °C min−1 ramp to
160 °C, a 20 °C min−1 ramp to 180 °C, a 3 °C min−1 ramp to
200 °C, and a 20 °C min−1 ramp to 220 °C held for 15 min.
The carrier gas (hydrogen) flow-rate was 4.0 mL min−1 (0.61
bar), measured at 50 °C. Split injection (1 : 40) was carried
out at 250 °C. Fatty acid identification was made by
comparing the relative retention times of FAME peaks from
samples with standards. The results were recorded and pro-
cessed using the CSW 1.7 Software (DataApex 1.7, Prague,
Czech Republic) and expressed in relative percentage of each
fatty acid.
2.4 Non-nutrient composition
2.4.1 Extraction procedure. The dry material was used to
prepare hydromethanolic extracts by adding 25 mL of
methanol : water (80 : 20 v/v) to 1 g of each sample. The extrac-
tion was carried out by stirring at 150 rpm for 1 h and sub-
sequently filtering through Whatman no. 4 paper. The residue
was then extracted with an additional 25 mL of methanol :
water (80 : 20 v/v) for another hour under the same conditions.
The combined extracts were evaporated at 40 °C in a rotary
evaporator (Büchi R-210, Flawil, Switzerland), frozen and lyo-
philized (FreeZone 4.5, Labconco, Kansas City, MO, USA).
2.4.2 Analysis of phenolic compounds. The previously
described hydromethanolic extracts were dissolved in water :
methanol (80 : 20, v/v) to a final concentration of 20 mg mL−1
and analysed using a Hewlett-Packard 1100 chromatograph
(Hewlett-Packard 1100, Agilent Technologies, Santa Clara, CA,
USA) with a quaternary pump and a diode array detector (DAD)
coupled to an HP Chem Station (rev. A.05.04) data-processing
station. A Waters Spherisorb S3 ODS-2 C18 (3 μm, 4.6 mm ×
150 mm) column thermostated at 35 °C was used. The solvents
used were: (A) 0.1% formic acid in water, (B) acetonitrile. The
elution gradient established was isocratic 15% for 5 min, 15%
B to 20% B over 5 min, 20–25% B over 10 min, 25–35% B over
10 min, and 35–50% for 10 min, and re-equilibration of the
column was performed using a flow rate of 0.5 mL min−1.
Double online detection was carried out in the DAD using
280 nm and 370 nm as preferred wavelengths and in a mass
spectrometer (MS) connected to a HPLC system via the DAD
cell outlet.21
MS detection was performed in an API 3200 Qtrap (Applied
Biosystems, Darmstadt, Germany) equipped with an ESI
source and a triple quadrupole-ion trap mass analyser that was
controlled by the Analyst 5.1 software. Zero grade air served as
the nebulizer gas (30 psi) and turbo gas was used for solvent
drying (400 °C, 40 psi). Nitrogen served as the curtain (20 psi)
and collision gas (medium). The quadrupoles were set at unit
resolution. The ion spray voltage was set at −4500 V in the
negative mode. The MS detector was programmed for record-
ing in two consecutive modes: enhanced MS (EMS) and
enhanced product ion (EPI) analysis. EMS was employed to
show full scan spectra, so as to obtain an overview of all of the
ions in a sample. The settings used were: declustering poten-
tial (DP) −450 V, entrance potential (EP) −6 V, collision energy
(CE) −10 V. The EPI mode was performed in order to obtain
the fragmentation pattern of the parent ion(s) in the previous
scan using the following parameters: DP −50 V, EP −6 V, CE
−25 V, and collision energy spread (CES) 0 V. Spectra were
recorded in the negative ion mode between m/z 100 and 1500.
The phenolic compounds were identified by comparing
their retention time, and UV-vis and mass spectra with those
obtained from standard compounds, when available. Other-
wise, peaks were tentatively identified from the information
obtained from their mass spectra and data reported in the lit-
erature. For quantitative analysis, a calibration curve for each
available phenolic standard was constructed based on the UV
Food & Function Paper
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signal: p-coumaric (y = 884.6x + 184.49; R2 = 0.999); kaemp-
ferol-3-O-glucoside (y = 288.55x − 4.0503; R2 = 1); kaempferol-
3-O-rutinoside (y = 239.16x − 10.587; R2 = 1); isorhamnetin-3-
O-glucoside (y = 218.26x − 0.98; R2 = 1); isorhamnetin-3-O-
rutinoside (y = 284.12x + 67.055; R2 = 0.999); quercetin-3-O-
glucoside (y = 363.45x + 117.86; R2 = 0.999), quercetin-3-O-
rutinoside (y = 281.98x − 0.3459; R2 = 1). For the detected phe-
nolic compounds for which a commercial standard was not
available, quantification was performed through the cali-
bration curve of other compounds from the same phenolic
group. The results were expressed in mg per g of the lyophi-
lized extract.
2.5 Antioxidant activity evaluation
For the antioxidant activity assays, the lyophilized hydrometha-
nolic extracts were dissolved in methanol : water (80 : 20 v/v)
and concentrated at 10 mg mL−1. For the diﬀerent assays,
these extracts were then subjected to further dilutions from
10 mg mL−1 to 0.02 mg mL−1.
The DPPH radical-scavenging activity was evaluated by
using an ELX800 microplate reader (Bio-Tek Instruments, Inc.;
Winooski, VT, USA), and calculated as a percentage of DPPH
discolouration using the formula: [(ADPPH − AS)/ADPPH] × 100,
where AS is the absorbance of the solution containing the
sample at 515 nm, and ADPPH is the absorbance of the DPPH
solution. The reducing power was evaluated by the capacity to
convert Fe3+ into Fe2+, measuring the absorbance at 690 nm in
the microplate reader mentioned above. Inhibition of β-caro-
tene bleaching was evaluated through the β-carotene/linoleate
assay; the neutralization of linoleate free radicals avoids β-caro-
tene bleaching, which is measured by the formula: (β-carotene
absorbance after 2 h of assay/initial absorbance) × 100. Lipid
peroxidation inhibition in porcine (Sus scrofa) brain homo-
genates was evaluated by the decrease in thiobarbituric acid
reactive substances (TBARS); the colour intensity of malondi-
aldehyde–thiobarbituric acid (MDA–TBA) was measured by its
absorbance at 532 nm; the inhibition ratio (%) was calculated
using the following formula: [(A − B)/A] × 100%, where A and B
were the absorbance of the control and the sample solutions,
respectively.21 The results were expressed in EC50 values
(sample concentration providing 50% of antioxidant activity or
0.5 of absorbance in the reducing power assay). Trolox was
used as the positive control.
2.6 Anti-inflammatory activity evaluation
2.6.1 Cell treatment. For the anti-inflammatory activity
assay, the lyophilized hydromethanolic extracts were dissolved
in water, and concentrated at 8 mg mL−1. For the diﬀerent
assays, the extracts were then subjected to further dilutions
from 8 mg mL−1 to 0.125 mg mL−1.
The mouse macrophage-like cell line RAW264.7 was cul-
tured in a DMEM medium supplemented with 10% heat-
inactivated foetal bovine serum, 100 U per mL penicillin and
100 mg per mL streptomycin and was incubated at 37 °C
under a humidified atmosphere containing 5% CO2. For each
experiment, cells were detached with a cell scraper. Under our
experiment on cell density (5 × 105 cells per mL), the pro-
portion of dead cells was less than 1%, according to Trypan
blue dye exclusion tests.
Cells were seeded in 96-well plates at 150 000 cells per well
and allowed to attach to the plate overnight. Then, the cells
were treated with diﬀerent concentrations of each of the
extract for 1 h. Dexamethasone (50 µM) was used as a positive
control for the experiment. The following step was stimulation
with LPS (1 µg mL−1) for 18 h. The eﬀect of all the tested
samples in the absence of LPS was also evaluated, in order to
observe if they induced changes in NO basal levels. In negative
controls, no LPS was added. Both extracts and LPS were dis-
solved in supplemented DMEM.
2.6.2 Nitric oxide determination. For the determination of
nitric oxide, the Griess Reagent System kit (Promega) was
used, which contains sulfanilamide, NED and nitrite solu-
tions. A reference curve of the nitrite was prepared in a 96-well
plate as described in the instructions thereof. One hundred
microliters of the cell culture supernatant were transferred to
the plate in duplicate and mixed with sulfanilamide and NED
solutions, 5–10 minutes each, at room temperature. The nitrite
produced was determined by measuring the optical density at
515 nm, in the microplate reader referred above, and com-
pared to the standard calibration curve.
2.7 Hepatotoxicity evaluation
The eﬀect of the samples on the growth of porcine liver
primary cells (PLP2), established by the group, was evaluated
by the sulforhodamine B (SRB) colorimetric assay with some
modifications as described by Abreu et al.28 Briefly, the liver
tissues were rinsed in Hank’s balanced salt solution contain-
ing 100 U per mL penicillin and 100 µg per mL streptomycin
and divided into 1 × 1 mm3 explants. Some of these explants
were placed in 25 cm3 tissue flasks in DMEM supplemented
with 10% fetal bovine serum, 2 mM nonessential amino acids
and 100 U per mL penicillin, and 100 mg per mL streptomycin
and incubated at 37 °C under a humidified atmosphere con-
taining 5% CO2. The medium was changed every 2 days. Culti-
vation of the cells was continued with direct monitoring every
2–3 days using a phase contrast microscope. Before conflu-
ence, cells were sub-cultured and plated in 96-well plates at a
density of 1.0 × 104 cells per well, and cultivated in DMEM
medium with 10% FBS, 100 U per mL penicillin and 100 µg
per mL streptomycin. Cells were treated for 48 h with the
diﬀerent diluted sample solutions and the SRB assay was per-
formed. The results were expressed in GI50 values (sample con-
centration that inhibited 50% of the net cell growth).
Ellipticine was used as the positive control.
2.8 Statistical analysis
For all the experiments, three samples were analyzed and all
the assays were carried out in triplicate. The results are
expressed as mean values ± standard deviation (SD). The diﬀer-
ences between the diﬀerent samples were analyzed using one-
way analysis of variance (ANOVA) followed by Tukey’s honestly
significant diﬀerence post hoc test with α = 0.05, coupled with
Paper Food & Function
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Welch’s statistic. This analysis was carried out using the SPSS
v. 22.0 program.
3. Results and discussion
3.1 Nutritional composition
The results obtained for macronutrients are presented in
Table 1. Carbohydrates were the major macronutrients found
in all the samples (85.6 to 88.2 g per 100 g), with slightly
higher amounts in red and white globe amaranth, followed by
ash and protein. Pink globe amaranth contained the highest
levels of ash (7.5 g per 100 g) and fat (1.20 g per 100 g)
whereas red and white globe amaranth showed a slightly
higher energy (381 and 380 kcal per 100 g, respectively), in
agreement with their higher levels of carbohydrates.
The chemical composition of the samples in hydrophilic
(sugars and organic acids) and lipophilic (fatty acids and toco-
pherols) compounds is shown in Table 1. Fructose, glucose
and sucrose were found in all the samples, with red and pink
globe amaranth revealing higher total sugar contents (2.47 and
2.40 g per 100 g, respectively). The levels of individual sugars
were similar in the three samples, with fructose being slightly
more abundant in red globe amaranth (0.76 g per 100 g) and
glucose in pink globe amaranth (1.66 g per 100 g). In a recent
study carried out by Pereira et al.,29 the infusions obtained
from these same samples of Gomphrena showed carbohydrate
concentrations below the detection limit, which could be
explained by the low levels present in the original plant
material.
Regarding organic acids, white globe amaranth revealed
the highest total amount (1.32 g per 100 g), with a signifi-
cant contribution of oxalic acid (1.16 g per 100 g), which was
also the prevailing organic acid in the other samples; red
globe amaranth presented a higher concentration of malic
acid (0.20 g per 100 g) and was also revealed to possess
fumaric acid, although in a very low concentration (0.007
g per 100 g).
Regarding tocopherols, white and pink globe amaranth
showed similar levels of γ-tocopherol (1.04 and 1.09 mg per
100 g) and total tocopherols (1.37 and 1.38 mg per 100 g,
respectively). α-Tocopherol was found in higher concentrations
in red globe amaranth (0.55 mg per 100 g) that was the only
sample where δ-tocopherol was not detected.
Up to 20 fatty acids were identified in the studied samples,
with prevalence of saturated fatty acids (SFA) and poly-
unsaturated fatty acids (PUFA) over monounsaturated fatty acids
(MUFA). Red globe amaranth revealed the highest percentages
of SFA (58.5%), with the main contribution of palmitic (C16:0;
34.6%) and stearic (C18:0; 8.1%) acids. MUFA were predomi-
nant in pink globe amaranth (8.2%) that presented oleic
(C18:1n9; 7.1%) and eicosenoic (C20:1; 0.30%) acids, whereas
PUFA prevailed in white (45.9%) and pink (45.6%) amaranth
due to the significant contributions of linoleic (C18:2n6; 31.9
and 30.2%, respectively) and α-linolenic (C18:3n3; 13.7 and
15.07%, respectively) acids.
Table 1 Nutritional value and nutrients in the globe amaranth cultivars
Red White Pink
Ash (g per 100 g dw) 5.4 ± 0.2c 6.1 ± 0.3b 7.5 ± 0.4a
Protein (g per 100 g dw) 5.9 ± 0.3a 5.6 ± 0.2a 5.70 ± 0.01a
Fat (g per 100 g dw) 0.50 ± 0.03c 0.80 ± 0.02b 1.20 ± 0.06a
Carbohydrates (g per 100 g dw) 88.2 ± 0.3ª 87.5 ± 0.3a 85.6 ± 0.2b
Energy (kcal per 100 g dw) 381 ± 1ª 380 ± 1a 376 ± 1b
Fructose (g per 100 g dw) 0.76 ± 0.01a 0.53 ± 0.03b 0.57 ± 0.02b
Glucose (g per 100 g dw) 1.58 ± 0.04ab 1.52 ± 0.07b 1.66 ± 0.09a
Sucrose (g per 100 g dw) 0.13 ± 0.02b 0.17 ± 0.01a 0.17 ± 0.03a
Total sugars (g per 100 g dw) 2.47 ± 0.06a 2.22 ± 0.04b 2.40 ± 0.04a
Oxalic acid (g per 100 g dw) 0.82 ± 0.01c 1.16 ± 0.01a 0.95 ± 0.02b
Malic acid (g per 100 g dw) 0.20 ± 0.01a 0.16 ± 0.03b 0.14 ± 0.01c
Fumaric acid (g per 100 g dw) 0.0070 ± 0.0002 nd nd
Total organic acids (g per 100 g dw) 1.03 ± 0.02c 1.32 ± 0.01a 1.09 ± 0.01b
α-Tocopherol (mg per 100 g dw) 0.55 ± 0.03a 0.28 ± 0.02b 0.23 ± 0.01c
γ-Tocopherol (mg per 100 g dw) 0.50 ± 0.04b 1.04 ± 0.06a 1.09 ± 0.05a
δ-Tocopherol (mg per 100 g dw) nd 0.05 ± 0.01 0.06 ± 0.01
Total tocopherols (mg per 100 g dw) 1.05 ± 0.07b 1.37 ± 0.08a 1.38 ± 0.03a
C16:0 (palmitic acid; %) 34.6 ± 0.4 25.7 ± 0.4 25.3 ± 0.1
C18:0 (stearic acid; %) 8.1 ± 0.1 5.93 ± 0.09 4.65 ± 0.02
C18:1n9 (oleic acid; %) 5.38 ± 0.02 4.91 ± 0.09 7.1 ± 0.3
C18:2n6 (linoleic acid; %) 23.6 ± 0.3 31.9 ± 0.3 30.2 ± 0.2
C18:3n3 (α-linolenic acid; %) 10.8 ± 0.9 13.7 ± 0.8 15.07 ± 0.05
C22:0 (behenic acid; %) 3.94 ± 0.02 5.65 ± 0.02 5.08 ± 0.03
SFA (%) 58.5 ± 0.5a 48.9 ± 0.5b 46.1 ± 0.4c
MUFA (%) 6.0 ± 0.1b 5.2 ± 0.1c 8.2 ± 0.3a
PUFA (%) 35.5 ± 0.5b 45.9 ± 0.6a 45.6 ± 0.1a
dw – dry weight; nd – not detected. SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA – polyunsaturated fatty acids. Only the
fatty acids with abundance higher than 5% were presented in the table; the diﬀerence to 100% corresponds to other fourteen less abundant fatty
acids. In each row diﬀerent letters mean statistically significant diﬀerences (p < 0.05).
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3.2 Composition in phenolic compounds
Data (retention time, λmax in the visible region, pseudomolecu-
lar ions and main fragment ions observed in MS2) obtained by
HPLC-DAD-ESI/MS regarding phenolic compound identifi-
cation and quantification in the analyzed samples of globe
amaranth are presented in Tables 2 and 3. As an example, the
profile of phenolic compounds in pink globe amaranth is
shown in Fig. 1.
The same twenty phenolic compounds, all of them flavo-
noid glycosides, were detected in both pink (Gomphrena sp.)
and white (Gomphrena globosa var. albiflora) globe amaranth,
fourteen of which had been already reported in inflorescences
of purple globe amaranth (Gomphrena globosa L.) previously
analyzed in our laboratory,21 so that the same identities have
been assumed. The remaining six compounds (i.e., 1, 5, 8, 15,
16 and 17 in Table 2) have been assigned based on their mass
Table 2 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of
phenolic compounds in white and pink globe amaranth (mean ± SD)
Peak
Rt
(min)
λmax
(nm)
Molecular ion
[M − H]− (m/z)
Main MS2
fragments (m/z) Tentative identification
Quantification
(mg g−1 extract)
White Pink
1 16.7 354 741 609(8), 301(40) Quercetin 3-O-(2-pentosyl,6-rhamnosyl)-hexoside 0.12 ± 0.01 0.12 ± 0.01
2 17.9 354 595 301(100) Quercetin 3-O-(6-pentosyl)-hexoside 0.12 ± 0.01 0.15 ± 0.01
3 18.8 354 609 301(100) Quercetin 3-O-rutinoside 5.21 ± 0.01 4.93 ± 0.10
4 19.1 340 725 593(10), 285(40) Kaempferol 3-O-(2-pentosyl,6-O-rhamnosyl)-hexoside 0.92 ± 0.03 1.22 ± 0.05
5 19.7 356 593 285(100) Kaempferol 3-O-(6-rhamnosyl)-hexoside 0.36 ± 0.01 0.44 ± 0.02
6 20.2 356 463 301(100) Quercetin 3-O-glucoside 0.71 ± 0.01 0.73 ± 0.02
7 21.1 352 579 447(10), 285(35) Kaempferol 3-O-(2-pentosyl)-hexoside 0.20 ± 0.01 0.22 ± 0.01
8 21.6 358 505 301(100) Quercetin O-acetylhexoside tr 0.018 ± 0.003
9 22.3 350 593 285(100) Kaempferol 3-O-rutinoside 3.27 ± 0.03 3.31 ± 0.01
10 23.3 352 623 315(100) Isorhamnetin 3-O-rutinoside 0.71 ± 0.02 0.75 ± 0.01
11 23.9 350 447 285(100) Kaempferol 3-O-glucoside 0.47 ± 0.02 0.52 ± 0.02
12 24.9 358 477 315(100) Isorhamnetin 3-O-glucoside 0.31 ± 0.01 0.36 ± 0.03
13 26.0 346 477 315(100) Isorhamnetin O-hexoside 0.39 ± 0.01 0.39 ± 0.01
14 26.7 346 489 285(100) Kaempferol O-acetylhexoside 0.25 ± 0.01 0.29 ± 0.01
15 28.5 340 563 285(100) Kaempferol O-rhamnosyl-pentoside 0.15 ± 0.01 0.19 ± 0.01
16 29.3 276, 340 607 313(100) Gomphrenol 3-O-(2-pentosyl)-hexoside 0.32 ± 0.01 0.36 ± 0.03
17 30.7 280, 334 649 313(100) Gomphrenol 3-O-(2-pentosyl,6 acetyl)-hexoside 0.21 ± 0.01 0.31 ± 0.03
18 31.8 338 639 463(39), 301(30) Quercetin O-glucuronide-O-hexoside 0.037 ± 0.001 0.08 ± 0.01
19 32.3 278, 342 475 313(100) Gomphrenol 3-O-hexoside 0.39 ± 0.01 0.40 ± 0.01
20 33.9 276, 340 517 313(100) Gomphrenol 3-O-(6-acetyl)-hexoside 0.84 ± 0.03 0.84 ± 0.01
Total phenolic compounds 14.99 ± 0.14 15.62 ± 0.20
Table 3 Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, identiﬁcation and quantiﬁcation of
phenolic compounds in the red variety of globe amaranth (mean ± SD)
Peak
Rt
(min)
λmax
(nm)
Molecular ion
[M − H]− (m/z) MS2 (m/z) Tentative identification
Quantification
(mg g−1)
1′ 15.1 354 799 315(100) Isorhamnetin-O-glucuronyl-deoxyhexosyl-hexoside 0.25 ± 0.00
2′ 16.8 354 653 315(100) Isorhamnetin-O-glucuronyl-hexoside 0.83 ± 0.00
3′ 17.2 312 163 119(100) p-Coumaric acid 1.00 ± 0.04
4′ 18.9 356 609 301(100) Quercetin-3-O-rutinoside 1.27 ± 0.00
5′ 19.4 354 639 331(36), 316(16) Patuletin O-deoxyhexosyl-hexoside 0.39 ± 0.03
6′ 20.2 358 463 301(100) Quercetin-3-O-glucoside 0.45 ± 0.03
7′ 20.6 354 493 331(60), 316(22) Patuletin O-hexoside 0.45 ± 0.00
8′ 22.0 336 829 635(22), 513(56), 315
(100), 193(20)
Unknown nq
9′ 25.1 348 681 343(96), 328(51) Methoxy-trihydroxymethylenedioxyflavone
O-glucuronyl-hexoside
1.07 ± 0.04
10′ 26.4 346 637 329(100) 3,5,3′,4′-Tetrahydroxy-6,7-methylenedioxyflavone-
3-O-deoxyhexosyl-hexoside
3.83 ± 0.01
11′ 27.2 348 767 723(79), 343(98), 328(48) Malonyl derivative of compound 9 0.83 ± 0.01
12′ 28.1 342 825 681(90), 343(36), 328(22) Derivative of compound 9 0.40 ± 0.01
13′ 29.0 338 491 329(56), 179(3) 3,5,3′,4′-Tetrahydroxy-6,7-methylenedioxyflavone-3-O-hexoside 0.65 ± 0.01
14′ 30.0 346 493 447(60), 328(5), 315(8) Unknown methylenedioxyflavone 3.03 ± 0.02
Total phenolic compounds 14.46 ± 0.03
nq – not quantified.
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spectral characteristics. In contrast to purple globe amaranth,
no hydroxycinnamoyl derivatives have been found in the
samples of white and pink globe amaranth now studied.
Compound 1 presented a pseudomolecular ion [M − H]− at
m/z 741 releasing fragments at m/z 609 ([M − H − 132]−, loss
of a pentosyl moiety) and 301 (quercetin; further loss of the
deoxyhexosylhexoside residue, −308 mu). Although these data
do not inform about the nature and substitution position of
the sugar moieties, compound 1 was tentatively identified as
quercetin 3-O-(2-pentosyl,6-O-rhamnosyl)-hexoside owing to
the previous identification of such a compound in inflores-
cences of G. globosa by Ferreres et al.30
Compound 5 showed a pseudomolecular ion [M − H]− at
m/z 593 yielding an MS2 fragment at m/z 285 (kaempferol) with
the loss of the deoxyhexosylhexoside residue. The compound
was identified as kaempferol 3-O-rutinoside, which corres-
ponds to peak 9, as confirmed by a comparison with a com-
mercial standard. Buschi & Pomilio31 in another Gomphrena
species (G. martiana) reported the presence of flavonol 3-O-
robinosides, whereas Ferreres et al.30 detected a similar
compound in G. globosa that was identified as kaempferol 3-O-
(6-rhamnosyl)-hexoside based on mass spectra, without indi-
cating the nature of the hexose. Since no support to the type of
sugar substituent can be concluded from the HPLC-DAD-MS
analysis performed herein, the same identity as suggested by
Ferreres et al.30 was assumed for compound 5. Compound 8
was associated with a quercetin O-acetylhexoside according
to its pseudomolecular ion [M − H]− at m/z 505 and the MS2
fragment released at m/z 301 ([M − H − 42 − 162]−, loss of
acetyl and hexosyl moieties). Compound 15 ([M − H]− at
m/z 563) could correspond to a kaempferol derivative bearing
pentosyl and rhamnosyl moieties. Only one MS2 fragment at
m/z 285 resulting from the loss of a disaccharide was pro-
duced, suggesting that both sugars are located on the same
position of the aglycone. Therefore, this compound was tenta-
tively assigned as kaempferol O-rhamnosyl-pentoside. As far as
we know, none of these compounds has been previously
identified in G. globosa.
Compounds 16 and 17 ([M − H]− at m/z 607 and 649 mu,
respectively) originated a base peak at m/z 313 mu, which
could correspond to gomphrenol (3,5,4′-trihydroxy-6,7-methyl-
enedioxyflavone) previously described in G. globosa leaves.32
Peaks with the same pseudomolecular ions were detected in
G. globosa inflorescences by Ferreres et al.30 and Silva et al.20
and were suggested to correspond to gomphrenol 3-O-(2-pento-
syl)-hexoside and gomphrenol 3-O-(2-pentosyl,6-acetyl)-hexo-
side; so, these identities were also tentatively assumed for the
compounds detected in our samples. Flavonoids bearing a
methylenedioxy group, like gomphrenol (3,5,4′-trihydroxy-6,7-
methylenedioxyflavonol), are rare in nature, with a predomi-
nance in the genus Gomphrena.33
Red globe amaranth (Gomphrena haageana K.) presented a
diﬀerent phenolic profile (Table 3) when compared with white
and pink samples. Fourteen phenolic compounds were
detected, from which only two coincided with those observed
in the other two Gomphrena species, namely quercetin 3-O-ruti-
noside (compound 4′) and quercetin 3-O-glucoside (compound
6′). Both flavonols, as well as compound 3′ (p-coumaric acid)
were positively identified by comparison with commercial
standards, having also been previously reported in other globe
amaranth varieties.20,21,30
Compounds 1′ ([M − H]− at m/z 799) and 2′ ([M − H]− at m/z
653) would correspond to isorhamnetin derivatives (λmax
around 354 nm and the common MS2 fragment at m/z 315)
Fig. 1 Phenolic proﬁle of the pink globe amaranth variety recorded at 370 nm.
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bearing diﬀerent numbers of sugar substituents. No infor-
mation about the identity of the sugar moieties and location
onto the aglycone could be obtained, although the fact that
only one MS2 fragment was released in both cases suggested
that sugars are attached to a unique position in the form of
oligosaccharides. Thus, according to their molecular masses
they were assigned as isorhamnetin O-glucuronyl-deoxy-
hexosyl-hexoside and isorhamnetin O-glucuronyl-hexoside,
respectively.
Compounds 5′ ([M − H]− at m/z 639) and 7′ ([M − H]− at m/z
493) released a main MS2 fragment at m/z 331 from the loss of
deoxyhexosyl-hexoside (308 mu) and hexoside (162 mu) moi-
eties, respectively. The ion at m/z 331 would fit patuletin,
whose presence was reported in other species of the genus
Gomphrena.33 Thus, the compounds were tentatively identified
as patuletin O-deoxyhexosyl-hexoside and patuletin O-hexo-
side, respectively. This latter might correspond to patuletin
3-O-glucoside described in G. claussenii Moq. by Ferreira &
Dias.33
Compounds 9′–14′ have been assigned as possible methyl-
enedioxyflavonol derivatives, based on their mass spectra and
the previous description of similar derivatives in inflores-
cences of G. globosa by Ferreres et al.30 Compound 13′ showed
a pseudomolecular ion [M − H]− at m/z 491 that released an
MS2 fragment at m/z 329 (−162 mu; loss of a hexosyl residue),
which was assumed to correspond to the deprotonated agly-
cone matching the structure of a tetrahydroxymethyl-
enedioxyflavone. It was tentatively identified as 3,5,3′,4′-
tetrahydroxy-6,7-methylenedioxyflavone-3-O-hexoside, as pre-
viously described by Ferreres et al.30 Similarly, compound 10′
([M − H]− at m/z 637) releasing a unique MS2 fragment at m/z
329 (−308 mu) should correspond to the equivalent deoxyhexo-
syl-hexoside derivative. Compound 9′ with an ion [M − H]− at
m/z 681 releasing fragments at m/z 343 (−338 mu; loss of glu-
curonyl + hexosyl residues) and 328 (−15 mu; further loss of a
methyl residue) might correspond to a methoxy-trihydroxy-
methylenedioxyflavone O-glucuronylhexoside. Compound 11′
([M − H]− at m/z 767) presented a molecular mass 86 mu
higher than compound 9′ and the same MS2 fragments at m/z
343 and 328, together with another fragment at m/z 723
(−44 mu; possible loss of a CO2 group). These characteristics
pointed out to a malonyl derivative of compound 9′. Com-
pound 12′ must also be related to compound 9′ owing to the
observation of the MS2 fragments at m/z 681, 343 and 328, as
well as by the existence of similar UV absorption spectra;
however, no final structure could be drawn. No identity could
be assigned to compound 14′, either, although the presence of
a fragment at m/z 328 suggested that it may also be related to
compound 9′, thus also belonging to the group of methyl-
enedioxyflavones. But for compound 13′, reported by Ferreres
et al.,30 none of the previous compounds has been described
in G. globosa, as far as we are aware.
Lastly, the minor compound 8′ presented a MS2 fragmenta-
tion pattern and a UV spectrum that did not allow a tentative
identification of its structure.
Quercetin 3-O-rutinoside (compound 3) was the major flavo-
nol found in white and pink globe amaranth (Table 2), fol-
lowed by kaempferol 3-O-rutinoside (compound 9), which
was also previously reported by us to be the main flavonoid
in the purple variety. As for red globe amaranth, the majority
compound was compound 10′, a tetrahydroxy-methyl-
enedioxyflavone (Table 3). To our knowledge, this is the first
report about the phenolic composition of red, white and pink
species of globe amaranth.
3.3 Antioxidant activity
The results of the antioxidant activity, based on radical scaven-
ging and lipid peroxidation inhibition capacities of the hydro-
methanolic extracts obtained for red, white and pink globe
amaranth are presented in Table 4. Among the three studied
samples, pink globe amaranth showed the highest antioxidant
activity, with the lowest EC50 values in all assays (0.25 to
1.02 mg mL−1), followed by red (0.41 to 1.30 mg mL−1) and
white (0.57 to 1.47 mg mL−1) globe amaranth. The best results
Table 4 Antioxidant and anti-inﬂammatory properties, and hepatotoxicity of the hydromethanolic extracts obtained from the globe amaranth
cultivars
Red White Pink
Antioxidant activity (EC50 values, mg mL
−1)
DPPH scavenging activity 1.19 ± 0.06b 1.36 ± 0.03a 1.02 ± 0.01c
Reducing power 0.88 ± 0.01b 1.38 ± 0.03a 0.84 ± 0.02c
β-Carotene bleaching inhibition 1.30 ± 0.04b 1.47 ± 0.04a 0.98 ± 0.06c
TBARS inhibition 0.41 ± 0.01b 0.57 ± 0.01a 0.25 ± 0.03c
Anti-inflammatory activity (EC50 values, µg mL
−1)
NO production 136 ± 4b 198 ± 5a 133 ± 7b
Hepatotoxicity (GI50 values, µg mL
−1)
PLP2 growth inhibition >400 >400 >400
Results of the antioxidant activity are expressed in EC50 values: sample concentration providing 50% of the antioxidant activity or 0.5 of
absorbance in the reducing power. Results of the anti-inflammatory activity are expressed in EC50 values: sample concentration providing 50% of
inhibition in the production of NO. Results of hepatotoxicity are expressed in GI50 values: sample concentration providing 50% of inhibition of
the net cell growth. In each row diﬀerent letters mean significant diﬀerences between samples (p < 0.05).
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of the antioxidant activity were obtained in the TBARS assay,
where the extracts revealed lipid peroxidation inhibition
activity at the lowest concentrations (EC50 between 0.25 and
0.57 mg mL−1).
To the best of our knowledge, there are no studies regard-
ing the antioxidant activity of the cultivars studied in the
present work, although there are a couple of reports on metha-
nolic extracts21 and infusions20 of purple globe amaranth, also
from Portugal but from diﬀerent distributors. Regarding the
DPPH scavenging activity of the infusions, Silva et al.20
reported EC50 values of 0.47 mg mL
−1, whereas the methanolic
extract studied by Roriz et al.21 showed a lower antioxidant
activity (1.47 to 4.87 mg mL−1) than that achieved with the
hydromethanolic extracts of the samples studied in the
present work (0.25 to 1.47 mg mL−1).
3.4 Anti-inflammatory activity and hepatotoxicity
In the course of the screening of natural products to find novel
anti-inflammatory drugs, the capacity of red, white and pink
globe amaranth to inhibit the NO release from macrophages
was also tested. As shown in Fig. 2, the hydromethanolic
extracts of the samples revealed a dose-dependent anti-inflam-
matory activity in the range of concentrations checked (up to
400 µg mL−1), with a considerable decrease of NO production
even for the low concentrated extracts. Pink and red
globe amaranth showed the lowest EC50 values (133 and
136 µg mL−1, respectively), with white globe amaranth revealing
a slight higher activity (198 µg mL−1). The extracts lack toxicity
when tested in the PLP2 cell line (established as primary cul-
tures from pig liver), even at the highest concentration studied
(400 μg mL−1) (Table 4). As far as we know, this is the first
report on the anti-inflammatory properties of these Gomphrena
species cultivars and, from the results obtained, they should
be considered as potential anti-inflammatory medicines.
4. Conclusion
Overall, the phytochemical profiles and bioactive properties of
diﬀerent cultivars of globe amaranth (red, white and pink)
have been compared, so as to contribute to the characteriz-
ation of these less studied Gomphrena species. To the best of
the authors’ knowledge, this is the first detailed chemical
study on the mentioned varieties and data obtained highlight
them as sources of bioactive compounds that could be in-
corporated in functional beverages or foods, as also in other
formulations, owing to their anti-inflammatory potential and
valuable properties related to oxidative stress.
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